AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SEED INNOVATIONS LIMITED

Pre-Annual General Meeting Information Aug 9, 2022

7909_rns_2022-08-09_b76e64e5-70e9-402a-8e9d-1970f77441e8.html

Pre-Annual General Meeting Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2922V

Seed Innovations Limited

09 August 2022

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

09 August 2022

SEED Innovations Ltd ("SEED" or, the "Company")

Notice of AGM & Investor Presentation

SEED Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space, is pleased to announce that the Company's Annual General Meeting ('AGM') will be held at 2 p.m. (BST) on 7 September 2022 at Obsidian House, Rue D'Aval, Vale, Guernsey and virtually via Investor Meet Company (see instructions to enable participation below). The Notice of AGM and accompanying Form of Proxy will be issued to shareholders shortly and, along with the Annual Report for the year ended 31 March 2022 which was announced on 21 July 2022, is available on the Company's website www.seedinnovations.co.

In order to ensure that shareholders are able to follow the proceedings of the AGM, the Company will provide access online through the Investor Meet Company platform. However, shareholders will not be able to vote online during the meeting and are therefore urged to submit their votes via proxy as early as possible.

In addition, Ed McDermott, CEO, Lance de Jersey, Finance Director, and Alfredo Pascual VP of Investment Analysis, will provide a live presentation at the AGM via the Investor Meet Company platform on 7 September 2022 at 2 p.m. (BST).

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet SEED Innovations Limited via: https://www.investormeetcompany.com/seed-innovations-limited/register-investor

Investors who already follow SEED Innovations Limited on the Investor Meet Company platform will automatically be invited.

ENDS

For further information on the Company please visit    www.seedinnovations.co   or contact:

Ed McDermott /

Lance de Jersey
SEED Innovations Ltd E:    [email protected]
James Biddle /

Roland Cornish
Beaumont Cornish Limited,

Nomad
T: +44 (0) 207 628 3396
Isabella Pierre /

Damon Heath
Shard Capital Partners LLP T: +44 (0)20 7186 9927
Catherine Leftley /

Max Bennett
St Brides Partners Ltd,

Financial PR
E: [email protected]

Notes

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCDZGGRZRNGZZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.